In the next three years, we will welcome the spring of "artificial intelligence + medical"
From wearable artificial intelligence devices to driverless cars, artificial intelligence (hereafter known as 'AI'), known as the new round of technological revolution, continues to be hot. The involvement of capital and the landing of various application scenarios seem to indicate that the era of AI is coming. Yang Hao, general manager of the intelligent AI business unit of HKUST, said in an interview on April 25 that the real AI+ medical enterprise must have pragmatic spirit and core technology to solve the application pain point and realize the technological revolution. Only enterprises that meet the above conditions can Embrace the spring of AI+ medical care after 3-5 years. Choosing high-tech barriers to overcome According to the data, HKUST's current main business is industrial automation and power automation, with B-side applications and customers as the mainstay. For C-side, especially in the medical field, there is no previous experience. Yang Hao said, "The choice of AI+ medical health is based on the company's intelligent experience and the imbalance of medical resources in China, and the serious problem of doctors and patients. We hope to cultivate the market through this field and lay the foundation for the future. We also hope that through innovative technologies, we can help solve the above social problems and practice corporate social responsibility." It is understood that in 2016, HKUST Intelligence has set its sights on the AI+ medical field, and it is the most difficult and complicated brain. HKUST Intelligence and the Fudan University Brain Intelligence Science and Technology Research Institute jointly established the "Fudan-Keda Intelligent Intelligent Robot Joint Laboratory"; invested in Beijing Yasen Technology Development Co., Ltd. (hereinafter referred to as "Ya Sen Technology") to achieve "images" "+" "Health Consultant" productization. "The reason why we chose the brain to do our field is mainly because we use the brain as the crown position of AI+ medical care. Whether it is imaging materials or robots, we can truly master the core technology if we overcome it." Yang Hao said, "Many artificial intelligence companies that have appeared in the past two years are starting from artificial intelligence technology or algorithms, looking for simple application scenarios to achieve landing, and lung nodules are clearly becoming a field where everyone can get together to achieve applications, due to lung nodules. A lot of data on this part of the video data will be available in public academic materials, it is easy to form products, and the technical threshold is low. For example, the Yasen technology we invest in, when they need to apply for lung nodules, they only use 3 The application of lung nodules AI has been achieved in a month. The brain is different, and its image data must be acquired in depth after deep cooperation with the hospital." To determine the areas to focus on, HKUST Intelligence also needs to find the right helper to help them get on the right track. “Yang Hao, who has seen almost all the AI+ medical imaging companies in the market at the time,†said Yang Hao. “Ultimately we chose Yasen Technology. The reason for the selection is also very simple. We are looking for a leading company in the segment, and we can be pragmatic. , a partner who works hard." Especially in the brain, Yasen Technology has an absolute leading edge. It is reported that the company has been rooted in nuclear medicine for many years, and has leading advantages in brain diseases such as AD (Alzheimer's disease) and epilepsy, and has matured in productization and commercialization. experience. Going to the "Knockout" before spring "I think that in the next 3-5 years, it will be the spring of AI+ medical enterprises. With the implementation of national policies, a large number of AI+ medical products will be applied to the application. However, there will not be many enterprises that can truly embrace spring." Yang Hao said . In Yang Hao's view, the excessive involvement of capital will allow the artificial intelligence market to experience a brutal “removal war†before entering the spring. "At present, most artificial intelligence will be eliminated because it is difficult to achieve product landing and cannot be profitable. Because the medical field is a mechanism for early phase-out, unlike sharing bicycles, it is first marketed and then eliminated. The medical industry attaches great importance to safety. At the same time, it is also recognized by hospital doctors. More importantly, medical products have officially landed in China. At present, CFDA system certification is required. Many companies have not obtained this article." It is understood that with the approval of the top layer, the relevant state departments have already released the application of AI+ medical products, because the AI ​​auxiliary medical diagnosis method has a certain guiding effect on the doctor's judgment, and with the increase of the involvement of intelligent products, The responsibility for security is becoming more and more important, and the control of laws and regulations is becoming more stringent. At the same time, Yang Hao also explained the future development of the company in the field of artificial intelligence. "The cooperation with Yasen Technology and Fudan University will continue to deepen and increase. In addition, we will continue to look for companies with pragmatic spirit in the AI+ medical field. Embrace the spring together." (China Securities Journal) Burn Gel,First Aid Burn Gel,Sterilize Burn Gel,Burn Relief Gel Roosin Medical Co.,Ltd , https://www.roosinmedical.com